Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer

Published:2018-04-12 Issue:5 Volume:25 Page:507-512
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Takamoto Atsushi¹,Tanimoto Ryuta¹,Bekku Kensuke¹,Araki Motoo¹,Sadahira Takuya¹,Wada Koichiro¹,Ebara Shin¹,Katayama Norihisa²,Yanai Hiroyuki³,Nasu Yasutomo¹

Affiliation:

1. Department of Urology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

2. Department of Radiology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

3. Department of Pathology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13555/fullpdf

Reference27 articles.

1. Brachytherapy for patients with prostate cancer: American Society of Clinical Oncology/Cancer Care Ontario joint guideline update;Chin;J. Clin. Oncol.,2017

2. Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy;Stock;BJU Int.,2009

3. Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy;Merrick;Int. J. Radiat. Oncol. Biol. Phys.,2006

4. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?;Stone;J. Urol.,2010

5. Duration of androgen suppression in the treatment of prostate cancer;Bolla;N. Engl. J. Med.,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low‐dose‐rate brachytherapy for localized prostate cancer;International Journal of Urology;2021-11-11

2. Biochemical outcomes and predictive factors by risk group after permanent iodine-125 seed implantation: Prospective cohort study in 2,316 patients;Brachytherapy;2019-09